Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05589402 · ClinicalTrials.gov registry record · Phase 1
Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
A Phase 1 study of Stroke and Spinal Cord Injuries, sponsored by University of Texas Rio Grande Valley.
- Active
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05589402 is a Phase 1 study of Stroke and Spinal Cord Injuries that is active but no longer recruiting, run by University of Texas Rio Grande Valley. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05589402, a Phase 1 study of Stroke and Spinal Cord Injuries, is active but no longer recruiting, sponsored by University of Texas Rio Grande Valley.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are conducting a research study to try to improve rehabilitation interventions for individuals with spinal cord injury (SCI). In this study, the aim is to determine if temporarily numbing non-paralyzed arm muscles with an over-the-counter numbing cream while exercising paralyzed muscles, can improve the strength, function, and sensation of paralyzed muscles after a spinal cord injury.
Conditions Studied
Interventions
- DRUG Lidocaine Cream 5%
- OTHER Rehabilitation Movement Training
Study Locations (1)
Texas
- University of Texas Rio Grande Valley - Harlingen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-06-04 |
| Est. Completion | 2026-06-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05589402
The ClinicalTrials.gov registry entry for NCT05589402 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Texas Rio Grande Valley, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine Cream 5% is the first listed.
NCT05589402 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05589402 about?
NCT05589402 is a clinical study titled "Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI". The investigators are conducting a research study to try to improve rehabilitation interventions for individuals with spinal cord injury (SCI). In this study, the aim is to determine if temporarily numbing non-paralyzed arm muscles with an over-the-counter numbing cream while exercising paralyzed mu...
What is the current status of trial NCT05589402?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2019-06-04. Estimated completion is 2026-06-04.
What conditions does trial NCT05589402 study?
This clinical trial studies the following conditions: Stroke, Spinal Cord Injuries, Spine Disease.
What interventions are being tested in trial NCT05589402?
The interventions under investigation include: Lidocaine Cream 5% (DRUG), Rehabilitation Movement Training (OTHER).
Who is sponsoring clinical trial NCT05589402?
This trial is sponsored by University of Texas Rio Grande Valley, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05589402 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
Hybrid Robot+FES Stroke Rehabilitation
RECRUITING · Phase 1
-
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
RECRUITING · Phase 1
-
Facilitating Neuroplastic Changes of Acute Stroke Survivors
RECRUITING · Phase 1
-
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
RECRUITING · Phase 1
-
Accelerated rTMS vs. Sham for Stroke Apathy
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.